• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Demant

279.00 DKK

-0.07 %

Less than 1K followers

DEMANT

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.07 %
+11.78 %
+42.64 %
+30.74 %
+29.65 %
+3.26 %
-3.29 %
-23.33 %
+848.98 %

Demant operates in the medical technology sector. The company specializes in the development of hearing aids and hearing loops. The company operates on a global level where the products are sold under various brands. The products are available through the company's distributors and sales channels. In addition to its main business, the company conducts research in diagnostics for measuring hearing quality. The company was originally founded in 1904 and has its headquarters in Smörum.

Read more
Market cap
59.08B DKK
Turnover
15.13M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
11.8.
2026

Interim report Q2'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release06.05.2026 klo 13.30

Demant A/S: Expansion of Demant’s Executive Leadership Team

Demant
Regulatory press release05.05.2026 klo 18.10

Demant A/S: Interim Management Statement for Q1 2026

Demant
Regulatory press release08.04.2026 klo 12.04

Demant A/S: Completion of capital reduction

Demant

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release07.04.2026 klo 12.26

Demant A/S: Transactions with Demant shares by managers and closely related parties

Demant
Press release31.03.2026 klo 12.41

Demant A/S: Investor news - Demant completes divestment of Oticon Medical

Demant
Regulatory press release05.03.2026 klo 17.30

Demant A/S: Decisions of annual general meeting

Demant
Regulatory press release03.02.2026 klo 08.57

Demant A/S: Notice to annual general meeting

Demant
Regulatory press release03.02.2026 klo 08.34

Demant A/S: Changes to Demant's Board of Directors

Demant
Regulatory press release03.02.2026 klo 08.32

Demant A/S: Annual Report 2025

Demant
Regulatory press release03.02.2026 klo 08.31

Demant A/S: Annual Report 2025 and review of H2 2025

Demant
Press release30.01.2026 klo 14.04

Demant A/S: Investor news - Demant completes divestment of EPOS

Demant
Regulatory press release13.01.2026 klo 14.14

Demant A/S: Transactions with Demant shares by managers and closely related parties

Demant
Regulatory press release20.12.2025 klo 02.29

Demant A/S: Demant sells EPOS to ACCO Brands

Demant
Regulatory press release03.12.2025 klo 11.07

Demant A/S: Financial calendar 2026

Demant
Regulatory press release01.12.2025 klo 12.56

Demant A/S: Demant closes the acquisition of KIND

Demant
Press release19.11.2025 klo 13.40

Demant A/S: Investor news - Demant obtains regulatory approval for the acquisition of KIND

Demant
Regulatory press release04.11.2025 klo 18.04

Demant A/S: Interim Management Statement for Q3 2025

Demant
Press release22.10.2025 klo 09.49

Demant A/S: Investor news - Demant-owned Oticon announces the launch of Oticon Zeal™

Demant
Regulatory press release22.10.2025 klo 02.36

Demant A/S: Demant to sell Oticon Medical to Impilo

Demant
Regulatory press release09.10.2025 klo 18.53

Demant A/S: Niels B. Christiansen, Chair of the Board of Demant, will not stand for re-election

Demant